DISPOSITIONS (Details) (USD $)	3 Months Ended		9 Months Ended		0 Months Ended	9 Months Ended	1 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Jul. 18, 2013 Ibrutinib [Member] Royalty Agreement Terms [Member]	Sep. 30, 2013 Ibrutinib [Member] Royalty Agreement Terms [Member]	Sep. 30, 2013 Enterix [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of intangible assets					$ 485,000,000
Gain on sale of royalty rights	474,138,000	0	474,138,000	0		474,000,000
Loss on sale of businesses, net			$ (17,400,000)	$ 0			$ 40,000,000